World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
60538
World Ranking
11945
National Ranking
6125

Maximilian Diehn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maximilian Diehn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 662 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maximilian Diehn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maximilian Diehn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maximilian Diehn is affiliated with Stanford University in the United States and has contributed extensively to research in medicine, particularly in oncology and molecular biology. Their work spans a range of topics, with significant focus on cancer diagnostics and treatment methodologies.

The primary fields of study for this scientist include Medicine and Biochemistry, Genetics, and Molecular Biology. Within these broad areas, their research delves into several subfields such as Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology, and Pathology and Forensic Medicine.

Their research covers several main topics, including cancer genomics and diagnostics, lung cancer treatments and mutations, lung cancer diagnosis and treatment, lymphoma diagnosis and treatment, radiomics and machine learning in medical imaging, CAR-T cell therapy research, and advanced radiotherapy techniques.

Frequent publication venues for Maximilian Diehn include:

  • Blood
  • Journal of Clinical Oncology
  • Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics
  • Hematological Oncology

Notable recent papers authored or co-authored by this researcher are:

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer, 2020, JAMA Oncology
  • Integrating genomic features for non-invasive early lung cancer detection, 2020, Nature
  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer, 2021, Journal of Thoracic Oncology
  • ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group, 2022, Annals of Oncology
  • Cancer biomarkers: Emerging trends and clinical implications for personalized treatment, 2024, Cell

They have collaborated frequently with several co-authors, including Ash A. Alizadeh, David M. Kurtz, Stefan Alig, Billy W. Loo, and Mohammad Shahrokh Esfahani.

Best Publications

  • Robust enumeration of cell subsets from tissue expression profiles

    Aaron M. Newman;Chih Long Liu;Michael R. Green;Andrew J. Gentles

  • Determining cell type abundance and expression from bulk tissues with digital cytometry.

    Aaron M. Newman;Chloé B. Steen;Chloé B. Steen;Chih Long Liu;Andrew J. Gentles

  • Association of reactive oxygen species levels and radioresistance in cancer stem cells

    Maximilian Diehn;Robert W. Cho;Neethan A. Lobo;Tomer Kalisky

  • The prognostic landscape of genes and infiltrating immune cells across human cancers

    Andrew J Gentles;Aaron M Newman;Chih Long Liu;Scott V Bratman;Scott V Bratman

  • An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

    Aaron M Newman;Scott V Bratman;Jacqueline To;Jacob F Wynne

  • Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn

  • Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

    Yohei Shimono;Maider Zabala;Robert W. Cho;Neethan Lobo

  • Integrated digital error suppression for improved detection of circulating tumor DNA

    Aaron M Newman;Alexander F Lovejoy;Daniel M Klass;David M Kurtz

  • Individuality and variation in gene expression patterns in human blood

    Adeline R. Whitney;Maximilian Diehn;Stephen J. Popper;Ash A. Alizadeh

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Ryan Phillips;William Yue Shi;Matthew Deek;Noura Radwan

  • Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

    Aadel A. Chaudhuri;Jacob J. Chabon;Alexander F. Lovejoy;Aaron M. Newman

  • Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

    Keith Syson Chan;Inigo Espinosa;Mark Chao;David Wong

  • Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

    Yu Liang;Maximilian Diehn;Nathan Watson;Andrew W. Bollen

  • Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

    Jacob J. Chabon;Andrew D. Simmons;Alexander F. Lovejoy;Mohammad S. Esfahani

  • SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data

    Maximilian Diehn;Gavin Sherlock;Gail Binkley;Heng Jin

  • Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

    Maximilian Diehn;Christine Nardini;David S. Wang;Susan Lynne McGovern

  • Integrating genomic features for non-invasive early lung cancer detection

    Jacob J. Chabon;Emily G. Hamilton;David M. Kurtz;Mohammad S. Esfahani

  • Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

    Jennifer C. Boldrick;Ash A. Alizadeh;Maximilian Diehn;Sandrine Dudoit

  • Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

    Collin M Blakely;Thomas B K Watkins;Wei Wu;Beatrice Gini

  • Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers

    Andrew J. Gentles;Aaron M. Newman;Chih Long Liu;Scott V. Bratman

Frequent Co-Authors

Ash A. Alizadeh
Ash A. Alizadeh Stanford University
Heather A. Wakelee
Heather A. Wakelee Stanford University
Chih Long Liu
Chih Long Liu Stanford University
Patrick O. Brown
Patrick O. Brown Stanford University
Ranjana H. Advani
Ranjana H. Advani Stanford University
Quynh-Thu Le
Quynh-Thu Le Stanford University
Andrew J. Gentles
Andrew J. Gentles Stanford University
Davide Rossi
Davide Rossi European Society for Medical Oncology
Ronald Levy
Ronald Levy Stanford University
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in advancing your medical career without attending traditional on-campus classes? The landscape of online healthcare education in the USA is expanding, making healthcare degrees and career upgrades more accessible and affordable than ever.

Aspiring nurse practitioners can benefit from the cheapest online acute care nurse practitioner programs, which allow you to specialize in acute care while managing tuition costs. For those at the start of their nursing careers, online nursing programs cover everything from foundational courses to advanced practice, with flexible schedules well-suited for working students.

If you already hold an RN degree and wish to further your education, explore the most affordable accredited online rn to bsn programs, which provide a clear and affordable pathway to a bachelor's degree. Ambitious nurses looking to enter academia or research can consider the cheapest phd nursing programs, making advanced scholarship more attainable.

Online degrees can open doors to new opportunities in medicine, allowing you to balance professional growth with your personal and financial needs.

Best Scientists Citing Maximilian Diehn

Trending Scientists

Recently Published Articles